受强制性开放获取政策约束的文章 - Tomonori Tanei了解详情
可在其他位置公开访问的文章：6 篇
Capillary-wall collagen as a biophysical marker of nanotherapeutic permeability into the tumor microenvironment
K Yokoi, M Kojic, M Milosevic, T Tanei, M Ferrari, A Ziemys
Cancer research 74 (16), 4239-4246, 2014
强制性开放获取政策： US National Institutes of Health
Redirecting transport of nanoparticle albumin-bound paclitaxel to macrophages enhances therapeutic efficacy against liver metastases
T Tanei, F Leonard, X Liu, JF Alexander, Y Saito, M Ferrari, B Godin, ...
Cancer research 76 (2), 429-439, 2016
强制性开放获取政策： US National Institutes of Health
Serum biomarkers for personalization of nanotherapeutics-based therapy in different tumor and organ microenvironments
K Yokoi, T Tanei, B Godin, AL van de Ven, M Hanibuchi, A Matsunoki, ...
Cancer Letters 345 (1), 48-55, 2014
强制性开放获取政策： US National Institutes of Health
Antitumor activity of Cetuximab in combination with Ixabepilone on triple negative breast cancer stem cells
T Tanei, DS Choi, AA Rodriguez, DH Liang, L Dobrolecki, M Ghosh, ...
Breast Cancer Research 18, 1-9, 2016
强制性开放获取政策： US National Institutes of Health, Susan G. Komen
Enhanced performance of macrophage-encapsulated nanoparticle albumin-bound-paclitaxel in hypo-perfused cancer lesions
F Leonard, LT Curtis, P Yesantharao, T Tanei, JF Alexander, M Wu, ...
Nanoscale 8 (25), 12544-12552, 2016
强制性开放获取政策： US National Science Foundation, US National Institutes of Health
Liposomal doxorubicin extravasation controlled by phenotype-specific transport properties of tumor microenvironment and vascular barrier
K Yokoi, D Chan, M Kojic, M Milosevic, D Engler, R Matsunami, T Tanei, ...
Journal of Controlled Release 217, 293-299, 2015
强制性开放获取政策： US National Institutes of Health
出版信息和资助信息由计算机程序自动确定